Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Aug 9, 2013, after the close
10-Q filed Aug 9, 2013, 40 days after period end · 0001193125-13-328986
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $6.05M | $7.29M | $10.63M | $629.00K |
| Net Income | -$20.47M | -$22.49M | -$22.48M | -$32.71M |
| EPS Diluted | -$0.33 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.40 |
| -$0.42 |
| -$51.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
